发明名称 PODXL IN BLADDER CANCER
摘要 There is provided a method for determining whether a mammalian subject having a bladder cancer belongs to a first or a second group, wherein the prognosis of subjects of the second group is worse than the prognosis of subjects of the first group, comprising the steps of: a) evaluating an amount of PODXL in at least part of a sample earlier obtained from the subject and determining a sample value corresponding to the evaluated amount; b) comparing said sample value with a predetermined reference value; and if said sample value is higher than said reference value, c1) concluding that the subject belongs to the second group; and if said sample value is lower than or equal to said reference value, c2) concluding that the subject belongs to the first group.
申请公布号 WO2014095508(A1) 申请公布日期 2014.06.26
申请号 WO2013EP76179 申请日期 2013.12.11
申请人 ATLAS ANTIBODIES AB 发明人 JIRSTRÖM, KARIN
分类号 G01N33/50;G01N33/574 主分类号 G01N33/50
代理机构 代理人
主权项
地址